PCMM Portable, Continuous, Miniature and Modular Technology Rick - - PowerPoint PPT Presentation
PCMM Portable, Continuous, Miniature and Modular Technology Rick - - PowerPoint PPT Presentation
PCMM Portable, Continuous, Miniature and Modular Technology Rick Mitzner Senior Director, Engineering Technology Pfizer Global Engineering Pfizer Inc Sept 30, 2015 Portable, Continuous, Miniature & Modular A vision to transform SOD
A standardized SOD technology platform used for development and commercial production. The system uses continuous processing, with state-of-the-art technologies, enabling flexible batch size providing production-on-demand. The complete ‘containerized’ POD-based facility is pre-engineered and assembled in the field for fast deployment.
Portable, Continuous, Miniature & Modular
2
A vision to transform SOD Product Development and Manufacturing
- Open Innovation: platform available to the industry
- Leverage commercially available technologies
- Collaborate with key business partners
– Pfizer – Equipment Supplier (GEA) – Portable Facility Supplier (G-Con)
- Phase 2 collaboration planned
3
PCMM Development Approach
PCMM OSD: A Factory in a POD
Continuous Processing Platform Technology for Solid Oral Dosage Forms HSWG and CDC Skids Pre-fabricated in Belgium … and re-assembled into a grey space warehouse in Groton, CT Integrated into a ‘Portable’ cGMP POD 6 Modules Pre-fabricated in College Station Texas
Building 90 Mock-up
FAT in Belgium Shipped to Groton FAT in Texas Shipped to Groton
5
PCMM Videos
G-Con Video GEA Video
PCMM OSD Prototype Processing Equipment
Granule Conditioning Unit Total Elevation ~14.5 ft HSWG Wet Granulation Dryer
Continuous Mixing & Direct Compression ConsiGmaTM WG
CMT Mixer Tablet Press Feeders CMT Mixer Feeders Raw Material Dispensing
PCMM PAT and Product Diversion
Continuous Mixing & Direct Compression ConsiGmaTM WG
PAT 1 (NIR)
Post CMT Potency & Blend Uniformity
PAT 2 (NIR)
Post TSWG Granule Formation
PAT 3 (NIR)
Post Granule Sizing Potency & Granule Uniformity, Moisture
PAT 4 (FBRM)
Post Granule Sizing PSD
PAT 5 (NIR)
Feed Frame Potency & Blend/Granule Uniformity
Diversion 1 Post Fluid Bed Drying Diversion 2 Post Granule Sizing Diversion 3 Tablet Eject Chute
8
Batch to Continuous for OSD: Key Enablers & Differences
- Loss-in-weight feeders
– Low variability and high accuracy required
- Integration/automation across unit operations
– Balanced mass flow through entire processing system
- Product tracking/diversion
– In-line monitoring from beginning-of-run to end-of-run requiring – Proper mechanical access/sampling point design – Control strategy/logic to manage process deviations and interruptions
PCMM Assembled POD
Corridor/Entrance POD Raw Materials POD Technical Space Processing POD
9
PCM&M POD Layout
Raw Materials cGMP Space Airlock & Cleaning Tech Space Corridor/Entrance POD
10
Current State Batch Process
Transfer of Technology
Current State
Tech Transfer & Process Scale Up Tech Transfer & Process Scale Up
100 to 1000 kg <10 kg <100 kg
Commercial Supplies Phase III Clinical Supplies Phase IIB Clinical Supplies
Drug Product Quantities
(dry granulation / roller compaction)
Engineering Models Process Analytical Technology Advanced Process Control Experiments
│ 11
Transfer of Technology
Future State PCM&M
Platform Technology
Current State
Tech Transfer & Process Scale Up Tech Transfer & Process Scale Up
x x
100 to 1000 kg <10 kg <100 kg
Commercial Supplies Phase III Clinical Supplies Phase IIB Clinical Supplies
Drug Product Quantities
(dry granulation / roller compaction) │ 12
Future State
(dry blend / direct compaction)
several hours Flexible
time time
<1 hour
time
Process Analytical Technology Engineering Models Advanced Process Control Equipment Design
Integrated System
An Integrated Approach to a Platform Technology
An opportunity to transform the Development to Manufacture Paradigm
│ 13
World-class Material Science, Formulation & Development Practices World-class Commercial Manufacturing
~500 MM tab/year 24/5 operation, 30% downtime
PCMM Business Benefits
- Same continuous process for product development, clinical trials &
commercial production
- Eliminates scale-up, minimizes API consumption, reduces tech transfer risk
- Production-on-Demand lowers inventory and reduces risk of product
expiration
- Portable POD minimizes market entry investment with recoverable assets
- PAT and APC provide robust, adaptable process control and CPV
- Modular technology includes direct compression and wet granulation tablets
- Additional unit operations can be added (dry granulation, coating,
encapsulation, packaging, etc.)
14
15